Evidence map›Paper›PMID 34531658›Full record

ArticleNeuropsychiatric disease and treatment2021

Patient and Physician Perspectives of Depressive Symptoms and Expectations for Treatment Outcome: Results from a Web-Based Survey.

Jun Ishigooka, Tatsuya Hoshino, Takumi Imai, Hisako Yoshida, Midori Ono, Mihoko Ota, Yoshiya Moriguchi, Keita Fujikawa, Ayumi Shintani, Jovelle L Fernandez

Abstract read
In one paragraph

Article in Neuropsychiatric disease and treatment, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jun IshigookaInstitute of CNS Pharmacology, Tokyo, Japan.ORCID 0000-0003-0547-2843
Tatsuya HoshinoJapan Medical Office, Takeda Pharmaceutical Company Limited, Tokyo, Japan.ORCID 0000-0002-2357-7000
Takumi ImaiDepartment of Medical Statistics, Osaka City University Graduate School of Medicine, Osaka, Japan.ORCID 0000-0002-0541-3467
Hisako YoshidaDepartment of Medical Statistics, Osaka City University Graduate School of Medicine, Osaka, Japan.ORCID 0000-0002-5999-5773
Midori OnoJapan Medical Office, Takeda Pharmaceutical Company Limited, Tokyo, Japan.ORCID 0000-0003-1713-5289
Mihoko OtaJapan Medical Office, Takeda Pharmaceutical Company Limited, Tokyo, Japan.ORCID 0000-0002-0492-0192
Yoshiya MoriguchiMedical Affairs, Lundbeck Japan K.K., Tokyo, Japan.ORCID 0000-0001-9248-8864
Keita FujikawaJapan Medical Office, Takeda Pharmaceutical Company Limited, Tokyo, Japan.ORCID 0000-0003-2907-5359
Ayumi ShintaniDepartment of Medical Statistics, Osaka City University Graduate School of Medicine, Osaka, Japan.ORCID 0000-0002-3323-110X
Jovelle L FernandezJapan Medical Office, Takeda Pharmaceutical Company Limited, Tokyo, Japan.ORCID 0000-0001-5013-9789

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeA previous international study suggested that perceptions of depression symptoms, social function, and treatment expectations are different between patients/physicians. We aimed to examine whether such differences exist in Japan.

methodsA web-based survey was conducted with patients who reported that they had been diagnosed with depression, and physicians who reported that they had treated patients with depression, in Japan. Questionnaires were designed to quantify patients' perceptions of symptoms, social function, and treatment expectations. Patients were categorized into three stages of disorder based on their reported current symptoms: severe symptomatic, mild symptomatic, and remission. Physicians were assigned up to three patients, were provided with patient information from the questionnaire completed by those patients, and finally the completed questionnaire forms for each patient. Agreement between the perceptions of the patients and physicians was examined for each stage.

resultsOf the 2618 eligible patients, 828 were assigned to 326 eligible physicians. Overall, we found small differences in the perceptions of depression treatment between patients/physicians. Slightly fewer physicians than patients reported physical symptoms (85% vs 91%; p=0.018) in the mild symptomatic stage. Fewer physicians than patients reported cognitive symptoms in the severe (82% vs 87%; p=0.029) and mild (54% vs 66%; p=0.003) symptomatic stages. Social function was deemed to be lower by physicians than by patients, across all stages of disorder (p<0.001). Regarding treatment expectations, more physicians than patients reported "return to a normal life" in the mild symptomatic (51% vs 35%, p<0.001) and remission stages (57% vs 36%, p<0.001), and more patients than physicians reported "reduction of side effects" in the severe (10% vs 4%, p=0.004) and mild (12% vs 5%, p<0.001) symptomatic disorder stages.

conclusionThese results suggest small differences in patient/physician perceptions of depression treatment in Japan. Discrepancies between patients'/physicians' perceptions may vary depending on the medical environment.

Indexed as

depressionpatientperceptionphysicianweb-based survey

Identifiers

PMID34531658
PMCPMC8440229

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.